Page 923 - Latest News

Pre-Budget meetings with govt: Economists urge FM to push capex pedal

Some experts flagged that state governments' debt has become unsustainable

Goldman Sachs upgrades Indian stocks to 'overweight' on growth momentum

The global brokerage has set a 2026 year-end target of 29,000 for the benchmark index Nifty 50, implying a 14% upside from Friday's close

Bajaj Finance consolidated net profit up 23% to ₹4,948 crore in Q2

Bajaj Finance's standalone profit fell 24% to Rs 4,251 crore due to higher loan loss provisions and a high base last year, even as consolidated profit rose 23% on robust loan growth

Uttar Pradesh govt's growing microfinance kitty at ₹32,500 crore

In the quarter ending September 30, 2025, microfinance institutions (MFI) clocked a growth of almost 4 per cent, with quarterly lending at ₹7,258 crore

Festivals, GST rejig boost average credit card spending by 15%: RBI data

Credit card spending surged in September 2025 on strong festive demand and GST rationalisation, with private lenders such as HDFC Bank and ICICI Bank leading the growth in per-card spends

Centre monitoring US Supreme Court case against Donald Trump tariffs

Indian officials and experts are monitoring the US Supreme Court case challenging Donald Trump's tariff powers, assessing how the verdict may affect the proposed India-US trade agreement

Sustained growth acceleration holds key for Trent stock's recovery

Trent will tender around a 15 per cent stake in Inditex Trent Retail (Zara India) for ₹150 crore at ₹15,422 per share in a buyback

US, China suspend mutual shipping probes as trade talks ease tensions

The suspensions remove some costs and uncertainty for an industry that had been facing fees to deliver goods to the US

Lenskart lists flat after volatile debut; valuation debate lingers

Eyewear retailer Lenskart's stock fluctuated sharply on listing day, ending nearly unchanged as investors weighed its steep valuation and long-term growth potential

Canara Bank expects GST reforms to give credit growth a leg-up in H2

Canara Bank expects credit momentum to continue in H2 of FY26, supported by GST rate cuts, robust rural lending, and higher retail demand even as it works to maintain profitability and asset quality

In the AI game: Maya1 shows developing useful tools need not cost a bomb

It supports over 20 controllable speaking styles, including natural patterns like hesitation, excitement, and warmth

Red Fort blast: Avoid rumours, rely only on official word, says Delhi CM

Red Fort blast: The explosion was so powerful that it shattered the windows of vehicles parked several metres away and was heard in nearby buildings of the congested area

BBC's top bosses resign over Trump documentary row: All that happened

Tim Davie, who became BBC Director-General in 2020, and News Head Deborah Turness have stepped down after a Panorama episode allegedly misrepresented Trump's 2021 speech

Smart beta funds lose traction on performance slump, shows data

The decline in flows coincide with a slump in performance of such schemes in comparison to other passive equity schemes

Trump hosts Syria's interim Prez Al-Sharaa in landmark White House visit

White House press secretary Karoline Leavitt said Monday's visit is part of the president's efforts in diplomacy to meet with anyone around the world in the pursuit of peace

Tangerine: A journey of self and truth shaped by political change

It tells the story of an unexpected journey into Hindu philosophy during a period of personal turmoil

JK Tyre aiming for 20% export share in 5 years: CMD Raghupati Singhania

Company eyes growth in Europe, South America and Africa as Mexico output offsets US trade curbs

Radisson Hotel Group plans to expand to 200+ unique locations in India

India's infra growth and tier-II and III markets to drive demand

HNIs chase alpha via portfolio managers; discretionary PMS clients hit 200K

Discretionary PMS clients cross 200K; assets soar past ₹40 trillion

Pharma units likely to face action for Schedule M violations: Experts

The one-year grace period for MSME drug manufacturers to comply with revised Schedule M norms has ended, with the CDSCO instructing state regulators to initiate inspections & action against violators